AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17240929
Drug: Whitening paint-on
RxNorm normalized name: Castellani Paint
DrugBank: Phenol (DB03255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Whitening paint-on gel with polyethylene strip barrier
Trial: 7617798
Drug: Intravenous yohimbine
RxNorm normalized name: YOHIMBINE
DrugBank: Yohimbine (DB01392)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous yohimbine (0.4 mg/kg)
Trial: 14708414
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine (2 mg/kg)
Trial: 16229114
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil (CC) 16 mg + Hydrochlorothiazide (HCT) 12.5 mg
Trial: 7913205
Drug: Continuous insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous insulin infusion
Trial: 11973171
Drug: No insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No insulin (Control group)
Trial: 9537454
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with thymosin alpha1 (TA1) and interferon (IFN)
Trial: 1053432
Drug: Nasal spray
RxNorm normalized name: Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal spray containing phosphate-buffered saline (PBS) with human serum albumin
Trial: 18214709
Drug: Low-dose IV
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose IV cyclophosphamide (LD-CYC)
Trial: 29332237
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of acetaminophen
Trial: 23111035
Drug: Video game
RxNorm normalized name: sulfur
DrugBank: Octasulfur (DB09353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Video game play (more than 10 hours weekly)
Trial: 19730966
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of granisetron 0.1 mg iv and promethazine 6.25 mg iv
Trial: 12548201
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg norethindrone acetate/5 microg ethinyl estradiol
Trial: 6094655
Drug: Conventional antiulcer
RxNorm normalized name: ANTIULCER AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional antiulcer agents (Control)
Trial: 31492797
Drug: GRACE risk
RxNorm normalized name: Brace Relief
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GRACE risk score and associated treatment recommendations
Trial: 22500948
Drug: Extended-release niacin/laropiprant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release niacin/laropiprant (ERN/LRPT)
Trial: 15470966
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (morning light, evening light, placebo)
Trial: 19572082
Drug: Withholding anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withholding anticoagulant therapy after negative CCUS
Trial: 17631801
Drug: Low-dose Dinggui
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose Dinggui Oil (DGO-L, 0.8 g, 3 times daily)
Trial: 23177514
Drug: Regorafenib 160
RxNorm normalized name: Regorafenib
DrugBank: Regorafenib (DB08896)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Regorafenib 160 mg once daily for the first 3 weeks of each 4 week cycle
Trial: 21729277
Drug: Complex oral
RxNorm normalized name: vitamin B complex Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex oral health care (OHC) intervention
Trial: 31455425
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg intravenous (IV) zoledronic acid (ZA) in postmenopausal women.
Trial: 30109375
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group informed about the real nature of the cream
Trial: 21167363
Drug: Monthly training
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly training for 4 months
Trial: 10706042
Drug: Oral acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acyclovir 800 mg four times daily for 120 days (ACV)
Trial: 27655325
Drug: IV infusion
RxNorm normalized name: IV INFUSION SET (WINTHROP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV infusion of 4 mL/Kg of crystalloid over 5 minutes
Trial: 22398668
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg cilostazol
Trial: 1287138
Drug: Ceftibuten 400
RxNorm normalized name: ceftibuten 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftibuten 400 mg once daily
Trial: 8031347
Drug: Porcine surfactant
RxNorm normalized name: Secretin porcine
DrugBank: Secretin porcine (DB09527)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Porcine surfactant (4 g in 50 ml) delivered via bronchoscope
Trial: 28448426
Drug: Filorexant 10
RxNorm normalized name: Filorexant
DrugBank: Filorexant (DB12158)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filorexant 10 mg nightly
Trial: 7552517
Drug: Three 100
RxNorm normalized name: THREE-LOBE SAGE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three 100 microgram doses of the inactivated HIV‐1 antigen in incomplete Freund's adjuvant (IFA)
Trial: 16846587
Drug: Weekly betamethasone
RxNorm normalized name: Betamethasone
DrugBank: Betamethasone phosphate (DB14669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly betamethasone
Trial: 25376448
Drug: Etanercept (ETN)
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept (ETN) 50 mg BIW for 12 weeks followed by 50 mg QW for 12 weeks
Trial: 15548814
Drug: Niacin 500
RxNorm normalized name: niacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niacin 500 mg
Trial: 19952712
Drug: Continued protease
RxNorm normalized name: protease
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continued protease inhibitor regimen
Trial: 15672051
Drug: Intragastric balloon
RxNorm normalized name: CATHETER,BALLOON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intragastric balloon treatment
Trial: 8917026
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of ranitidine at 6.25 mg/hr (n = 9)
Trial: 12051570
Drug: 2 x
RxNorm normalized name: anti-HER2 x HER2 ADC
DrugBank: Zanidatamab zovodotin (DB15472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 x 80 mg/day Ginkgo special extract EGb 761
Trial: 322817
Drug: Oral flucloxacillin
RxNorm normalized name: cloxacillin Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral flucloxacillin (250 mg six-hourly for four days)
Trial: 23856779
Drug: Deleobuvir 100
RxNorm normalized name: Deleobuvir
DrugBank: Deleobuvir (DB14850)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deleobuvir 100 mg q8h for 5 days
Trial: 23856779
Drug: Deleobuvir 200
RxNorm normalized name: Deleobuvir
DrugBank: Deleobuvir (DB14850)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deleobuvir 200 mg q8h for 5 days
Trial: 23710718
Drug: Negative pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative pressure therapy (NPT)
Trial: 19702597
Drug: Carvedilol 25
RxNorm normalized name: carvedilol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol 25 mg/day (n=9)
Trial: 15902161
Drug: Sham ExMI
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham ExMI treatment
Trial: 17560293
Drug: Simvastatin plus
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin plus L-arginine (3 g/day) in subjects with high ADMA
Trial: 17560293
Drug: Simvastatin plus
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin plus L-arginine (3 g/day) in subjects with low ADMA
Trial: 11555383
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) at approximately half the microgram dose for 6 months
Trial: 27606973
Drug: Etanercept monotherapy
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept monotherapy
Trial: 7503614
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no lisinopril)
Trial: 27803392
Drug: Intra-arterial therapy
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial therapy (IAT)
Trial: 26621909
Drug: Persistently elevated
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Persistently elevated C-reactive protein (CRP) level (≥ 5 mg/L at both baseline and 24 weeks after ART initiation)
Trial: 24445737
Drug: UVA irradiation
RxNorm normalized name: UVA URSI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UVA irradiation of the skin with two standard erythemal doses
Trial: 26945817
Drug: Antioxidant-pregabalin combination
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant-pregabalin combination
Trial: 15309258
Drug: Dexpanthenol nasal
RxNorm normalized name: Dexpanthenol
DrugBank: Dexpanthenol (DB09357)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexpanthenol nasal ointment (5%)
Trial: 2204333
Drug: Continuous interpleural
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous interpleural infusion of bupivacaine (n = 8)
Trial: 14769785
Drug: Sulfafurazole (sulphisoxazole)
RxNorm normalized name: sulfafurazole
DrugBank: Sulfisoxazole (DB00263)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulfafurazole (sulphisoxazole) 50 mg/kg body weight, given once a day for six months
Trial: 7746775
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate (BDP) 500 micrograms (two puffs of Becloforte) with a 750 ml spacer
Trial: 31339676
Drug: Low-dose efavirenz
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose efavirenz (EFV400)
Trial: 30766533
Drug: IL-1β blocker
RxNorm normalized name: IL-1 TRAP
DrugBank: Rilonacept (DB06372)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IL-1β blocker anakinra
Trial: 12942722
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate (CA) monotherapy - 300 mg/day
Trial: 12942722
Drug: Maximal androgenic
RxNorm normalized name: Spirulina maxima preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maximal androgenic block (MAB) - CA + surgical castration - 200 mg/day
Trial: 23943299
Drug: Hormonal therapy
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal therapy (HT)
Trial: 27883215
Drug: Adalimumab combination
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adalimumab combination therapy
Trial: 17907591
Drug: CFC-based budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: CFC-based budesonide inhaler therapy
Trial: 20192896
Drug: No sodium
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No sodium thiosulfate (STS) infusion (Control)
Trial: 18462572
Drug: Bulk-forming laxatives
RxNorm normalized name: Bulk-forming laxatives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bulk-forming laxatives
Trial: 18462572
Drug: Stimulant laxatives
RxNorm normalized name: STIMULANT LAXATIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulant laxatives
Trial: 18462572
Drug: Adverse effects
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adverse effects of treatment
Trial: 1991925
Drug: Aztreonam treatment
RxNorm normalized name: Aztreonam
DrugBank: Aztreonam (DB00355)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aztreonam treatment
Trial: 2472262
Drug: Pentagastrin infusion
RxNorm normalized name: pentagastrin
DrugBank: Pentagastrin (DB00183)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentagastrin infusion (control)
Trial: 17706003
Drug: Safety Control
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Safety Control (another antipsychotic)
Trial: 8872628
Drug: Erythrocyte infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythrocyte infusion
Trial: 31074816
Drug: Combined high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined high intake of both vitamins (B6 ≥35 mg/d and B12 ≥20 μg/d)
Trial: 14762880
Drug: Concurrent and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent and adjuvant chemotherapy
Trial: 17413103
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g fat/d (5 g fat/meal)
Trial: 17413103
Drug: 29 g
RxNorm normalized name: Publix Pen Needle 29 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 29 g fat/d (10 g fat/meal)
Trial: 9451466
Drug: 5-month individualized
RxNorm normalized name: moth bean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-month individualized progressive resistance training programme (moderate intensity, high volume) twice a week
Trial: 15621801
Drug: Low IPI
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low IPI and rituximab therapy
Trial: 24149079
Drug: AS03(B)-adjuvanted vaccine
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS03(B)-adjuvanted vaccine
Trial: 19745215
Drug: Nonadjuvanted vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonadjuvanted vaccine
Trial: 23880306
Drug: ART according
RxNorm normalized name: clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ART according to national treatment eligibility guidelines
Trial: 21793317
Drug: Eleutherococcus senticosus
RxNorm normalized name: Eleutherococcus Senticosus Root
DrugBank: Eleuthero (DB14303)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eleutherococcus senticosus (ES) 800 mg/d
Trial: 10545552
Drug: iNO at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iNO at 20 ppm (after initial treatment with 2 ppm)
Trial: 21192262
Drug: Cancer vaccines
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cancer vaccines (specific formulations not detailed)
Trial: 19333170
Drug: Interlaminar epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interlaminar epidural steroid injections (IL ESIs)
Trial: 7382535
Drug: Group 2
RxNorm normalized name: Chlamydophila psittaci biogroup 2 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2 (0.5 mg/kg hydralazine)
Trial: 11979153
Drug: Gadodiamide at
RxNorm normalized name: Gadodiamide
DrugBank: Gadodiamide (DB00225)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gadodiamide at a dose of 0.1 mmol/kg
Trial: 11137267
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg doses at 3-day intervals
Trial: 25505191
Drug: Intranasal jasmine
RxNorm normalized name: jasmine oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal jasmine flower extract (JFE)
Trial: 5307603
Drug: Acetone-killed agar-grown
RxNorm normalized name: Agar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetone-killed agar-grown dried vaccine (vaccine K-66)
Trial: 10598760
Drug: Azelaic acid
RxNorm normalized name: Azelaic Acid
DrugBank: Azelaic acid (DB00548)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Azelaic acid 20% cream
Trial: 7853733
Drug: Carbachol infusion
RxNorm normalized name: Carbachol
DrugBank: Carbamoylcholine (DB00411)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbachol infusion (19 eyes)
Trial: 19381108
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy based on ARBs plus ACE inhibitors
Trial: 2798542
Drug: Mecamylamine 2.5
RxNorm normalized name: mecamylamine 2.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mecamylamine 2.5 mg
Trial: 29797911
Drug: Acupuncture combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture combined with western medicine
Trial: 7843425
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups received gonadotropin-releasing hormone agonist in follicular phase (flare-up) protocols
Trial: 16040714
Drug: Intracoronary L-NMMA
RxNorm normalized name: L-NMMA
DrugBank: Tilarginine (DB11815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary L-NMMA plus dobutamine
Trial: 7871062
Drug: Melatonin 10
RxNorm normalized name: melatonin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 10 mg
Trial: 29045514
Drug: anti-PD-1 antibody
RxNorm normalized name: Monoclonal antibody anti-SSEA-1
DrugBank: Fanolesomab (DB14211)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: anti-PD-1 antibody (Ab)
Trial: 29150857
Drug: 170 μg
RxNorm normalized name: dimethicone
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 170 μg LPP
Trial: 29150857
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment groups (70 μg, 170 μg, 370 μg)
Trial: 9733503
Drug: Substance P
RxNorm normalized name: Substance P
DrugBank: Substance P (DB19198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Substance P antagonist MK-869
Trial: 16943535
Drug: Prostate cancer
RxNorm normalized name: Leuprolide Acetate 22.5mg Lyophilisate for suspension for injection [Prostate Cancer] with Diluent, Transfer Device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostate cancer treatment (surgery, radiotherapy, watchful waiting, hormone therapy)
Trial: 25694060
Drug: Imeglimin 1500
RxNorm normalized name: Fosaprepitant Dimeglumine
DrugBank: Fosaprepitant (DB06717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Imeglimin 1500 mg twice daily for 1 week
Trial: 27927938
Drug: 1 mA
RxNorm normalized name: TRAIL-R1 mAb
DrugBank: Mapatumumab (DB18945)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mA cathodal tDCS over the contralesional primary motor cortex for 20 minutes during daily therapy
Trial: 11055772
Drug: Betula 30c
RxNorm normalized name: Betula lenta whole
DrugBank: Betula lenta whole (DB14164)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betula 30c tablets
Trial: 9463204
Drug: Perioperative corticoid
RxNorm normalized name: Corticool
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative corticoid treatment (CC)
Trial: 19926058
Drug: Usual-dose sirolimus
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Usual-dose sirolimus
Trial: 30953467
Drug: Adjuvant hepatic
RxNorm normalized name: hepatitis B surface antigen vaccine
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant hepatic arterial infusion pump (HAIP) chemotherapy with 6 cycles of floxuridine, starting 4-12 weeks after surgery.
Trial: 19169289
Drug: Pegfilgrastim 18
RxNorm normalized name: Pegfilgrastim
DrugBank: Pegfilgrastim (DB00019)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pegfilgrastim 18 mg
Trial: 23575220
Drug: Griseofulvin 15
RxNorm normalized name: Griseofulvin
DrugBank: Griseofulvin (DB00400)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Griseofulvin 15 mg/kg/day
Trial: 19769599
Drug: Low-dose aripiprazole
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose aripiprazole adjunctive to antidepressant treatment (ADT)
Trial: 12796831
Drug: Oral ondansetron
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ondansetron 8 mg twice daily for seven days
Trial: 7740627
Drug: REC diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: REC diet (low-fat, 28% of energy, high-fibre, 3.3 g/MJ)
Trial: 17916138
Drug: Azimilide 125
RxNorm normalized name: Azimilide
DrugBank: Azimilide (DB04957)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azimilide 125 mg daily